Jose I Suarez1, Muniza K Sheikh2, R Loch Macdonald3, Sepideh Amin-Hanjani4, Robert D Brown5, Airton Leonardo de Oliveira Manoel3, Colin P Derdeyn6, Nima Etminan7, Emanuela Keller8, Peter D Leroux9, Stephan A Mayer10, Akio Morita11, Gabriel Rinkel12, Daniel Rufennacht13, Martin N Stienen8, James Torner6, Mervyn D I Vergouwen12, George K C Wong14. 1. Division of Neurosciences Critical Care, The Johns Hopkins University School of Medicine, 1800 Orleans Street, Sheikh Zayed Building, 3014C, Baltimore, MD, 21287, USA. jsuarez5@jhmi.edu. 2. The Emmes Corporation, Rockville, MD, USA. 3. University of Toronto, Toronto, ON, Canada. 4. University of Illinois at Chicago, Chicago, IL, USA. 5. Mayo Clinic, Rochester, MN, USA. 6. University of Iowa, Iowa City, IA, USA. 7. University of Duesseldorf, Düesseldorf, Germany. 8. University of Zurich, Zurich, Switzerland. 9. Main Line Health Care, Wynnewood, PA, USA. 10. Henry Ford Hospital, Detroit, MI, USA. 11. Nippon Medical School, Tokyo, Japan. 12. University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. 13. Klinik Hirslanden, Zurich, Switzerland. 14. Chinese University of Hong Kong, Shatin, Hong Kong.
Abstract
OBJECTIVES: The goal for this project was to develop a comprehensive set of common data elements (CDEs), data definitions, case report forms and guidelines for use in unruptured intracranial aneurysm (UIA) and subarachnoid hemorrhage (SAH) clinical research, as part of a new joint effort between the National Institute of Neurological Disorders and Stroke (NINDS) and the National Library of Medicine of the US National Institutes of Health. These UIA and SAH CDEs will join several other neurological disease-specific CDEs that have already been developed and are available for use by research investigators. METHODS: A Working Group (WG) divided into eight sub-groups and a Steering Committee comprised of international UIA and SAH experts reviewed existing NINDS CDEs and instruments, created new elements when needed and provided recommendations for UIA and SAH clinical research. The recommendations were compiled, internally reviewed by the entire UIA and SAH WG and posted online for 6 weeks for external public comments. The UIA and SAH WG and the NINDS CDE team reviewed the final version before posting the SAH Version 1.0 CDE recommendations. RESULTS: The NINDS UIA and SAH CDEs and supporting documents are publicly available on the NINDS CDE ( https://www.commondataelements.ninds.nih.gov/#page=Default ) and NIH Repository ( https://cde.nlm.nih.gov/home ) websites. The recommendations are organized into domains including Participant Characteristics and Outcomes and Endpoints. CONCLUSION: Dissemination and widespread use of CDEs can facilitate UIA and SAH clinical research and clinical trial design, data sharing, and analyses of observational retrospective and prospective data. It is vital to maintain an international and multidisciplinary collaboration to ensure that these CDEs are implemented and updated when new information becomes available.
OBJECTIVES: The goal for this project was to develop a comprehensive set of common data elements (CDEs), data definitions, case report forms and guidelines for use in unruptured intracranial aneurysm (UIA) and subarachnoid hemorrhage (SAH) clinical research, as part of a new joint effort between the National Institute of Neurological Disorders and Stroke (NINDS) and the National Library of Medicine of the US National Institutes of Health. These UIA and SAH CDEs will join several other neurological disease-specific CDEs that have already been developed and are available for use by research investigators. METHODS: A Working Group (WG) divided into eight sub-groups and a Steering Committee comprised of international UIA and SAH experts reviewed existing NINDS CDEs and instruments, created new elements when needed and provided recommendations for UIA and SAH clinical research. The recommendations were compiled, internally reviewed by the entire UIA and SAH WG and posted online for 6 weeks for external public comments. The UIA and SAH WG and the NINDS CDE team reviewed the final version before posting the SAH Version 1.0 CDE recommendations. RESULTS: The NINDS UIA and SAH CDEs and supporting documents are publicly available on the NINDS CDE ( https://www.commondataelements.ninds.nih.gov/#page=Default ) and NIH Repository ( https://cde.nlm.nih.gov/home ) websites. The recommendations are organized into domains including Participant Characteristics and Outcomes and Endpoints. CONCLUSION: Dissemination and widespread use of CDEs can facilitate UIA and SAH clinical research and clinical trial design, data sharing, and analyses of observational retrospective and prospective data. It is vital to maintain an international and multidisciplinary collaboration to ensure that these CDEs are implemented and updated when new information becomes available.
Entities:
Keywords:
Clinical trials; Common data elements; Observational studies; Outcomes; Subarachnoid hemorrhage; Unruptured intracranial aneurysms
Authors: Nima Etminan; Colin Derdeyn; Katharina A M Hackenberg; Max Wintermark; Philip M Meyers; Giuseppe Lanzino; Daniel Rüfenacht; Timo Krings; John Huston; Gabriel Rinkel Journal: Neurocrit Care Date: 2019-06 Impact factor: 3.210
Authors: Martin N Stienen; Johanna M Visser-Meily; Tom A Schweizer; Daniel Hänggi; R Loch Macdonald; Mervyn D I Vergouwen Journal: Neurocrit Care Date: 2019-06 Impact factor: 3.210
Authors: Philippe Bijlenga; Akio Morita; Nerissa U Ko; J Mocco; Sandrine Morel; Yuichi Murayama; Marieke J H Wermer; Robert D Brown Journal: Neurocrit Care Date: 2019-06 Impact factor: 3.210
Authors: Jose I Suarez; Muniza K Sheikh; R Loch Macdonald; Sepideh Amin-Hanjani; Robert D Brown; Airton Leonardo de Oliveira Manoel; Colin P Derdeyn; Nima Etminan; Emanuela Keller; Peter D Leroux; Stephan A Mayer; Akio Morita; Gabriel Rinkel; Daniel Rufennacht; Martin N Stienen; James Torner; Mervyn D I Vergouwen; George K C Wong Journal: Neurocrit Care Date: 2019-06 Impact factor: 3.210
Authors: Gisele Sampaio Silva; Nelson J Maldonado; Jorge H Mejia-Mantilla; Santiago Ortega-Gutierrez; Jan Claassen; Panayiotis Varelas; Jose I Suarez Journal: Neurocrit Care Date: 2019-12 Impact factor: 3.210
Authors: Pascal Salazar; Mario Di Napoli; Mostafa Jafari; Alibay Jafarli; Wendy Ziai; Alexander Petersen; Stephan A Mayer; Eric M Bershad; Rahul Damani; Afshin A Divani Journal: Neurocrit Care Date: 2020-04 Impact factor: 3.210
Authors: Sabah Rehman; Ronil V Chandra; Kevin Zhou; Darius Tan; Leon Lai; Hamed Asadi; Jens Froelich; Nova Thani; Linda Nichols; Leigh Blizzard; Karen Smith; Amanda G Thrift; Christine Stirling; Michele L Callisaya; Monique Breslin; Mathew J Reeves; Seana Gall Journal: Acta Neurochir (Wien) Date: 2020-06-30 Impact factor: 2.216
Authors: Martin N Stienen; Johanna M Visser-Meily; Tom A Schweizer; Daniel Hänggi; R Loch Macdonald; Mervyn D I Vergouwen Journal: Neurocrit Care Date: 2019-06 Impact factor: 3.210
Authors: Redi Rahmani; Jacob F Baranoski; Felipe C Albuquerque; Michael T Lawton; Tomoki Hashimoto Journal: Exp Neurol Date: 2022-03-25 Impact factor: 5.620
Authors: Jose I Suarez; Muniza K Sheikh; R Loch Macdonald; Sepideh Amin-Hanjani; Robert D Brown; Airton Leonardo de Oliveira Manoel; Colin P Derdeyn; Nima Etminan; Emanuela Keller; Peter D Leroux; Stephan A Mayer; Akio Morita; Gabriel Rinkel; Daniel Rufennacht; Martin N Stienen; James Torner; Mervyn D I Vergouwen; George K C Wong Journal: Neurocrit Care Date: 2019-06 Impact factor: 3.210
Authors: Shaurya Taran; Vatsal Trivedi; Jeffrey M Singh; Shane W English; Victoria A McCredie Journal: Neurocrit Care Date: 2020-06 Impact factor: 3.210
Authors: Jennifer Frontera; Shraddha Mainali; Molly McNett; Sherry H-Y Chou; Ericka L Fink; Courtney L Robertson; Michelle Schober; Wendy Ziai; David Menon; Patrick M Kochanek; Jose I Suarez; Raimund Helbok Journal: Neurocrit Care Date: 2020-08 Impact factor: 3.532
Authors: Peter Y M Woo; Joanna W K Ho; Natalie M W Ko; Ronald P T Li; Leo Jian; Alberto C H Chu; Marco C L Kwan; Yung Chan; Alain K S Wong; Hoi-Tung Wong; Kwong-Yau Chan; John C K Kwok Journal: BMC Neurol Date: 2020-11-03 Impact factor: 2.474